• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number VAMF3838C150TU
Medical Device Problem Codes Leak/Splash (1354); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Death (1802); Blood Loss (2597)
Date of Event 06/04/2018
Type of Reportable Event Death
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
A valiant stent graft system was planned for use in a patient for an aortic tear.It was reported that the patients wife called technical services asking why an id card was sent to her address for her husbands device as he had expired 2 weeks previously.It was reported that the patient had surgery for a tear in the aorta but never recovered from surgery.No additional clinical sequelae were reported.
 
Additional Manufacturer Narrative
Additional information was received for this case: the patient presented with a dissection/rupture and the valiant stent graft system was implanted.It was noted there was 50% coverage of the subclavian artery with approximately 1.2 cm of seal.After deployment of the valiant stent graft there was no leak seen.The following day a ct scan revealed the stent graft no longer had a proper seal and the patient continued bleeding into his chest and expired.Per the physician the death was related to the inadequate seal of the valiant stent graft.If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT CAPTIVIA - FF
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key7640826
Report Number2953200-2018-00897
Device Sequence Number1899523
Product Code MIH
UDI-Device Identifier00643169346956
UDI-Public00643169346956
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
P100040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source company representative,other
Initial Reporter Occupation Patient Family Member or Friend
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 10/24/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/04/2019
Device Model NumberVAMF3838C150TU
Device Catalogue NumberVAMF3838C150TU
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 06/04/2018
Supplement Date Received by Manufacturer07/05/2018
08/08/2018
10/23/2018
Initial Report FDA Received Date06/27/2018
Supplement Report FDA Received Date07/24/2018
10/03/2018
10/24/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Death;
Patient Age83 YR
-
-